Prognostic factors of malignant peritoneal mesothelioma: a retrospective study of 52 female patients.

Ma, Jianting; Zhang, Shengzhi

Ma, Jianting; Zhang, Shengzhi.

Affiliation

Ma J; Obstetrics and Gynecology Department, Yuyao People's Hospital of Zhejiang Province, Yuyao, 315400, Zhejiang, China. mjt9977@126.com.
Zhang S; Obstetrics and Gynecology Department, Yuyao People's Hospital of Zhejiang Province, Yuyao, 315400, Zhejiang, China.

World J Surg Oncol ; 20(1): 219, 2022 Jun 29.

Article in En | MEDLINE | ID: mdl-35765009

Subject(s)

Mesothelioma, Malignant; Peritoneal Neoplasms; Female; Humans; Ki-67 Antigen; Paclitaxel; Pemetrexed; Peritoneal Neoplasms/therapy; Platinum; Prognosis; Retrospective Studies

Key words

Cytoreductive surgery; Female malignant peritoneal mesothelioma; Pathological subtype; Pemetrexed; Prognosis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peritoneal Neoplasms / Mesothelioma, Malignant Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: World J Surg Oncol Year: 2022 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google